Randomized, double-blind, placebo-controlled parallel-group comparative study to investigate the efficacy in probiotics on intestinal environment in healthy subjects
- Conditions
- one
- Registration Number
- JPRN-UMIN000052110
- Lead Sponsor
- Matsumoto Health Lab
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 40
Not provided
1) Individuals who regularly use medicine that affect the gut microbiota such as Intestinal regulators, laxatives, etc. 2) Individuals who cannot stop ingestion of foods and supplements containing lactic acid bacteria, bifidobacteria, oligosaccharides, etc. 3) Individuals who have disease or serious medical history in liver, kidney, heart, lung, gastrointestinal tract, blood, endocrine system, or metabolism, etc. 4) Individuals who have drug allergy, food allergy or medical history. 5) Individuals who have milk allergy or lactose intolerance. 6) Individuals who are pregnant, under lactation or expecting to be pregnant during this study. 7) Individuals who participated in other clinical trials in the past 1 month or who are going to participate in other trials in this study period. 8) Any candidates considered to be inappropriate for this study by the principal investigator based on their background, physical examination, etc.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Intestinal environment (gut metabolites, gut microbiota)
- Secondary Outcome Measures
Name Time Method